Glazer Capital LLC’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-366,241
Closed -$27.5M 118
2015
Q3
$27.5M Buy
366,241
+143,744
+65% +$10.7M 3.42% 11
2015
Q2
$16.8M Buy
+222,497
New +$11.9M 1.84% 18

Glazer Capital LLC's KYTH Position: Q4 2015 in Review

Glazer Capital LLC sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 366,241 shares — an estimated $27.5M sold.

Glazer Capital LLC first reported a position in KYTH in Q2 2015 and held it in 2 quarters. The position peaked at $27.5M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Glazer Capital LLC reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Glazer Capital LLC sold 366,241 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $27.5M.
  • Glazer Capital LLC first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2015 and held it in 2 quarters.
  • Glazer Capital LLC's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $27.5M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Glazer Capital LLC's 13F filing for Q4 2015, filed 12 Feb 2016.